American Urological Association Annual Meeting


(Source: auanet.org)

Follow the Renal & Urology News live coverage of the American Urological Association annual meeting through the years.



2015 2014 2013 2012 2011

Latest AUA Meeting Coverage

Hematuria Evaluation in Primary Care Varies Widely

Hematuria Evaluation in Primary Care Varies Widely

Less than half of primary care providers refer patients with any degree of hematuria for urological evaluation.

Urine Cytology Stain Detects Urothelial Carcinoma

Urine Cytology Stain Detects Urothelial Carcinoma

The test displayed an overall high sensitivity for detecting bladder tumors.

Complete Hematuria Evaluation Occurs in Just 1 in 6 Patients

Complete Hematuria Evaluation Occurs in Just 1 in 6 Patients

Men at high-risk of bladder cancer were the most likely to be referred to urologists.

Salvage Cryo Outcomes Similar After EBRT, Brachytherapy

Salvage Cryo Outcomes Similar After EBRT, Brachytherapy

Study reveals comparable rates of freedom from biochemical failure at 5 years.

Early Tumor Shrinkage with TKIs Predicts mRCC Survival

Early Tumor Shrinkage with TKIs Predicts mRCC Survival

RCC tumor shrinkage significantly and independently predicted overall survival.

Early ADT for Recurrent Prostate Cancer May Hike Death Risk

Early ADT for Recurrent Prostate Cancer May Hike Death Risk

This effect appears to occur mainly in men who experience recurrence when they are younger than 65 and in those with low-risk cancer.

Neoadjuvant Sunitinib Linked to Improved Outcomes in RCC with Thrombus

Neoadjuvant Sunitinib Linked to Improved Outcomes in RCC with Thrombus

Neoadjuvant sunitinib was linked to primary tumor and thrombus shrinkage, reduced blood loss during surgery, as well as improved cancer-specific survival.

Scrotal US for Pain Rarely Reveals Absolute Surgery Indications

Scrotal US for Pain Rarely Reveals Absolute Surgery Indications

Study shows that 81% of scrotal ultrasounds for pain demonstrate normal or benign findings.

RCC Progression Rare After 10 Recurrence-Free Years Post-Nephrectomy

RCC Progression Rare After 10 Recurrence-Free Years Post-Nephrectomy

Pathological stage was the only independent factor linked to kidney cancer progression.

'Real-World' Patient Compliance with Bladder CA Therapy Poor

'Real-World' Patient Compliance with Bladder CA Therapy Poor

Researchers find rates lower than those observed in most clinical trials.

Intensive Local Therapy to RCC Bone Metastases May Increase Survival

Intensive Local Therapy to RCC Bone Metastases May Increase Survival

The approach was defined as surgical resection with a wide margin or radiotherapy with a biologically effective dose of 140 Gy or greater.

Delayed Stone Treatment Increases Morbidity

Delayed Stone Treatment Increases Morbidity

Unplanned clinical visits 15 times more likely among patients treated more than 45 days after diagnosis.

Metastasectomy May Up Survival in Metastatic RCC Patients

Metastasectomy May Up Survival in Metastatic RCC Patients

In a study, patients who had the procedure had a better 5-year overall survival rate than those who did not (68% vs. 27%).

Larger RCC Tumors Predict High-Grade Pathology

Larger RCC Tumors Predict High-Grade Pathology

New finding may inform treatment decisions.

Sign Up for Free e-newsletters